# Omada Health, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Omada Health, Inc.). ## Overview Omada Health, Inc. is a U.S.-based virtual care company that delivers evidence-based programs for chronic conditions through a human-led, technology-enabled care model. Its platform supports members between doctor visits across cardiometabolic and musculoskeletal care, with programs sold directly to employers and through health plans, PBMs, and health systems. ## Products & services • Virtual care programs for cardiometabolic conditions • Prevention & Weight Health program • Diabetes program • Hypertension program • GLP-1 companion support and prescribing capabilities • Musculoskeletal (MSK) care programs - **Cardiometabolic virtual care** (55%) — Programs for diabetes, hypertension, and related metabolic risk conditions delivered through ongoing member support. - **Prevention & Weight Health** (25%) — Behavior-change and weight-management programs aimed at prevention and metabolic health improvement. - **GLP-1 support services** (10%) — Companion services and prescribing-related support for members using obesity medications. - **Musculoskeletal care** (10%) — Virtual care programs focused on MSK conditions and related member support. - Virtual care programs for cardiometabolic conditions - Prevention & Weight Health program - Diabetes program - Hypertension program - GLP-1 companion support and prescribing capabilities - Musculoskeletal (MSK) care programs ## Customers Omada sells on a business-to-business-to-consumer basis, with customers that cover programs for employees, dependents, or patients. Core buyers include fully insured health plans, self-insured employers, PBMs, and health systems that assume financial risk for care delivery. Channel partners also resell Omada programs to their own end customers, which broadens access but can make the sales path more indirect. - **Self-insured employers** (primary) — Buy Omada programs for employees and dependents to manage chronic disease and weight-related risk. - **Health plans** (primary) — Purchase directly or act as channel partners to offer Omada to covered lives and employer groups. - **PBMs** (primary) — Resell Omada programs or cover them directly for members as part of broader benefit offerings. - **Health systems** (secondary) — Use Omada for patients in risk-bearing arrangements where reducing downstream cost matters. - **Government and Medicare Advantage** (emerging) — Emerging buyer base for broader covered-life expansion and new distribution channels. - Self-insured employers buying programs for employees and dependents - Fully insured health plans covering members through benefit arrangements - PBMs acting as channel partners and resellers to employer clients - Health systems covering patients under risk-bearing care models - Government-related buyers and Medicare Advantage prospects ## Geography Omada is headquartered in the United States and its business is primarily organized around U.S. employers, health plans, PBMs, and health systems. The reports provided do not disclose a country revenue split, but the company’s operating model, customer base, and regulatory exposure are centered on the U.S. healthcare market. - Headquartered in the United States - Primary customer base is U.S. employers and health plans - Sales and delivery are tied to U.S. healthcare benefit structures - Devices used in programs are manufactured in China and other markets - No country revenue split was disclosed in the excerpts ## Strategy Omada’s strategy centers on expanding covered lives by adding new customers, deepening relationships with existing channel partners, and increasing adoption of multiple programs per customer. The company is also focused on improving member enrollment and engagement, since those drive recurring program usage and the value proposition for buyers. - **Expand multi-program adoption** (medium-term) — Selling additional programs into existing accounts raises revenue per customer and improves retention. - **Raise member enrollment and engagement** (short-term) — More enrolled and active members directly increase services revenue and improve customer outcomes. - **Broaden distribution through channel partners** (medium-term) — Health plans and PBMs extend reach into employer and member populations at lower sales friction. - **Adapt the platform to obesity and GLP-1 care** (short-term) — The obesity market is evolving, and customers want support across medication and non-medication pathways. - Grow covered lives through new customers and channel partners - Increase multi-program adoption within existing accounts - Improve member enrollment rates through outreach and targeting - Strengthen data, analytics, operations, and customer success - Expand into new lines such as Medicare Advantage - Use GLP-1 support to address evolving obesity care demand ## Risks Omada depends on customers and channel partners recognizing clinical and economic value, so adoption risk is closely tied to proof of outcomes and member engagement. The business also faces concentration risk with major health plan and PBM partners, plus cybersecurity, privacy, and regulatory risks because it handles protected health information and operates in technology-enabled healthcare. - **Customer and channel partner concentration** [high] — A large share of revenue comes from a small number of health plan and PBM partners, increasing renewal and pricing risk. - **Clinical value and adoption risk** [high] — If customers do not believe the programs reduce cost or improve outcomes, market adoption can slow materially. - **Cybersecurity and data privacy** [high] — The company handles PHI and other sensitive data, so breaches or outages could disrupt operations and create liability. - **Member engagement and performance guarantees** [medium] — Contracts may require repayment of fees if engagement, outcomes, or savings targets are not met. - **Device sourcing and tariff exposure** [medium] — Connected devices are part of cardiometabolic programs and are largely manufactured in China, creating cost and supply risk. - Customer concentration with top health plan and PBM partners - Adoption depends on proving clinical outcomes and cost savings - Cybersecurity and PHI privacy exposure in digital healthcare delivery - Member engagement shortfalls can trigger fee repayment obligations - Supply chain and tariff risk for connected devices - Growth execution risk from limited operating history and rapid scaling ## Accounting Revenue recognition is judgmental because Omada bills monthly in arrears, recognizes some revenue upfront on hardware delivery or initial consultation, and then recognizes the remainder over the access period. Reported revenue can also shift with member mix, program mix, and engagement-based contract terms, while estimates for refunds or fee repayments may affect timing and amount recognized. - **Revenue recognition for virtual care programs** — Affects quarterly revenue timing and deferred revenue balances - **Variable consideration and performance guarantees** — Can reduce recognized revenue through reserves or clawback estimates - **Capitalized software and technology amortization** — Affects operating expense and asset carrying values - **Tax accounting for NOLs and uncertain positions** — Can affect deferred tax assets and tax expense - Revenue recognized over time for program access and partly upfront for hardware - Monthly billing in arrears affects timing of receivables and revenue - Program mix changes can shift revenue between Prevention, Diabetes, and Hypertension - Contracts may include repayment obligations tied to engagement or outcomes - Capitalized internal-use software and developed technology affect amortization - Uncertain tax positions and NOLs remain subject to tax authority review --- *Last updated: 2026-04-29T04:43:44.380020+00:00*